TY - JOUR T1 - TRAP1 chaperone protein mutations and autoinflammation JF - Life Science Alliance JO - Life Sci. Alliance DO - 10.26508/lsa.201900376 VL - 3 IS - 2 SP - e201900376 AU - Ariane SI Standing AU - Ying Hong AU - Coro Paisan-Ruiz AU - Ebun Omoyinmi AU - Alan Medlar AU - Horia Stanescu AU - Robert Kleta AU - Dorota Rowcenzio AU - Philip Hawkins AU - Helen Lachmann AU - Michael F McDermott AU - Despina Eleftheriou AU - Nigel Klein AU - Paul A Brogan Y1 - 2020/02/01 UR - https://www.life-science-alliance.org/content/3/2/e201900376.abstract N2 - We identified a consanguineous kindred, of three affected children with severe autoinflammation, resulting in the death of one sibling and allogeneic stem cell transplantation in the other two. All three were homozygous for MEFV p.S208C mutation; however, their phenotype was more severe than previously reported, prompting consideration of an oligogenic autoinflammation model. Further genetic studies revealed homozygous mutations in TRAP1, encoding the mitochondrial/ER resident chaperone protein tumour necrosis factor receptor associated protein 1 (TRAP1). Identification of a fourth, unrelated patient with autoinflammation and compound heterozygous mutation of TRAP1 alone facilitated further functional studies, confirming the importance of this protein as a chaperone of misfolded proteins with loss of function, which may contribute to autoinflammation. Impaired TRAP1 function leads to cellular stress and elevated levels of serum IL-18. This study emphasizes the importance of considering digenic or oligogenic models of disease in particularly severe phenotypes and suggests that autoinflammatory disease might be enhanced by bi-allelic mutations in TRAP1. ER -